These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 15456076)

  • 21. New data brings resistance testing closer to routine clinical use.
    Murphy MJ
    Fac Notes (New Orleans La); 1999; 11(3):6. PubMed ID: 11810872
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinically validated genotype analysis: guiding principles and statistical concerns.
    Brun-Vézinet F; Costagliola D; Khaled MA; Calvez V; Clavel F; Clotet B; Haubrich R; Kempf D; King M; Kuritzkes D; Lanier R; Miller M; Miller V; Phillips A; Pillay D; Schapiro J; Scott J; Shafer R; Zazzi M; Zolopa A; DeGruttola V
    Antivir Ther; 2004 Aug; 9(4):465-78. PubMed ID: 15456077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [GESIDA Consensus document on the use of resistance studies in clinical practice].
    Gatell JM; Blanco JL; Alcamí J; Antela A; Arrizabalaga J; Casado JL; Clotet B; Delgado R; Erice A; Guerra L; Guerrero A; Iribarren JA; Leal M; López JC; Menéndez-Arias L; Miró JM; Moreno S; Pérez JL; Pumarola T; Rubio R; Ruiz L; Santamaría JM; Soriano V; Telenti A; Viciana P
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):53-60. PubMed ID: 11428062
    [No Abstract]   [Full Text] [Related]  

  • 24. Antiretroviral update: recent advances expand options for patients with HIV.
    Santhanam H; Goins M
    Adv Nurse Pract; 2004 Nov; 12(11):53-4, 56. PubMed ID: 15559568
    [No Abstract]   [Full Text] [Related]  

  • 25. [Consensus documents and clinical guidelines on resistance to antiretroviral agents].
    Antela A; Iribarren JA; Clotet B; Guerra L
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):47-52. PubMed ID: 11428061
    [No Abstract]   [Full Text] [Related]  

  • 26. Update of the drug resistance mutations in HIV-1: 2004.
    Johnson VA; Brun-Vézinet F; Clotet B; Conway B; D'Aquila RT; Demeter LM; Kuritzkes DR; Pillay D; Schapiro JM; Telenti A; Richman DD
    Top HIV Med; 2004; 12(4):119-24. PubMed ID: 15516709
    [No Abstract]   [Full Text] [Related]  

  • 27. [Primary resistance to antiretroviral agents].
    Soriano V; María Miró J; Guerrero A
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):22-5. PubMed ID: 11428054
    [No Abstract]   [Full Text] [Related]  

  • 28. Outsmarting HIV.
    Fallon SJ
    Posit Aware; 2003; 14(2):37. PubMed ID: 12693374
    [No Abstract]   [Full Text] [Related]  

  • 29. HIV drug resistance: overview of clinical data.
    Miller V
    J HIV Ther; 2001 Aug; 6(3):68-71. PubMed ID: 11555740
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-resistant HIV: predicting the future.
    Laurence J
    AIDS Read; 2001 Oct; 11(10):485-6. PubMed ID: 11708079
    [No Abstract]   [Full Text] [Related]  

  • 31. The evolving role of antiretroviral drug resistance testing in HIV-infected individuals.
    Idemyor V
    HIV Clin Trials; 2002; 3(5):413-7. PubMed ID: 12407491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV drug resistance and you. Resistance overview. A look at the basics.
    Munk B
    Posit Aware; 2006; Spec No():6-9. PubMed ID: 16583502
    [No Abstract]   [Full Text] [Related]  

  • 33. Comment on: High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
    Raymond S; Delobel P; Izopet J
    J Antimicrob Chemother; 2010 Sep; 65(9):2056-7; author reply 2058-9. PubMed ID: 20554569
    [No Abstract]   [Full Text] [Related]  

  • 34. HIV drug resistance testing.
    AIDS Read; 2000 Mar; 10(3):149. PubMed ID: 10798889
    [No Abstract]   [Full Text] [Related]  

  • 35. Rapid assay for HIV drug resistance.
    Am Fam Physician; 1997 Oct; 56(6):1676-7. PubMed ID: 9351434
    [No Abstract]   [Full Text] [Related]  

  • 36. HIV/AIDS. Tangled patent dispute over 'free' drug-resistance database.
    Cohen J
    Science; 2009 Feb; 323(5918):1156-7. PubMed ID: 19251598
    [No Abstract]   [Full Text] [Related]  

  • 37. Testing gains shown in antiretroviral resistance. Research addresses new recommendations.
    AIDS Alert; 2003 Sep; 18(9):114-7. PubMed ID: 14686306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiretroviral resistance testing. A necessary element in the follow-up of the HIV-infected patient].
    Alcamí J; Rubio R
    Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):1-2. PubMed ID: 11428052
    [No Abstract]   [Full Text] [Related]  

  • 39. Revisiting resistance (this isn't getting any easier).
    Mascolini M
    IAPAC Mon; 2000 Aug; 6(8):221-38. PubMed ID: 11299604
    [No Abstract]   [Full Text] [Related]  

  • 40. Successful application of laboratory tools for the detection of HIV drug resistance in routine clinical care in Georgia.
    Chkhartishvili N; Dvali N; Gochitashvili N; Sharvadze L; Tsertsvadze T
    Georgian Med News; 2008 Dec; (165):16-22. PubMed ID: 19124911
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.